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We are what we are because ofthe kind of the kidneys we have. 
Homer Smith 
A B S T R A C T 
owadays the number of the patients with chronic renal failure and the syndrome of end-stage renal disease 
permanently increases. New dietary regimens are necessary to improve the status of the patients with severe 
kidney diseases. Nutrition plays an essential role in the contemporary approach to the management of the pa­
tients with renal failure. Low-protein diet delays the progression of the renal failure. The meta-analysis of the 
effect of dietary protein restriction on the course of diabetic and non-diabetic renal diseases outlines the im­
portance of the adequate correction of the uremic syndrome and the absence of side effects of this nutritional 
regimen. The development of appropriate diet therapy to be administered at the predialytic stage of the dis­
ease could prevent or at least delay the progression of chronic renal failure and, in this way, it represents a 
challenge for the nephrologists and hope for the patients. 
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Contemporary approach to the management and the new 
dietary therapy of kidney diseases with chronic renal failure 
(CRF) defined a standpoint of modern nephrology. 
Circumstances will inevitably dictate the strategy of dietary 
gimen in a patient with CRF who could be critically ill, or 
sitting in an outpatient consulting room. Obviously it is es­
sential to confirm the stage of renal failure, with particular 
emphasis on reversible factors, which require immediate by 
specific therapeutic complication by the best form of re­
placement therapy. 
Spontaneous slowing of progression is also seen in only 10 
to 12% of cases of patients with CRF whose progression 
has apparently stopped are unlikely, to consent to a change 
of supplements in low protein diet. The trial the Modifica­
tion of Diet in Renal Disease (MDRD) study (1994) evalu­
ated the beneficial effect of dietary protein restriction in pa­
tients with renal diseases of diverse etiology. 
he objective of these studies was to determine whether a 
low-protein diet retards the progression of renal failure. 
MDRD study indicated that patients with moderate renal 
failure (GFR at 25-55ml/min; study A) faster decline in 
mean GFR during the first 4 months after randomization 
but a slower mean decline thereafter in patients who were 
prescribed a low-protein diet (0,58g/kg/day) compared to a 
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usual protein diet (1,3g/kg/day), but no significant differ­
ence in the level of GFR at 3 years of follow-up. In patients 
with more advanced renal insufficiency (GFR levels at 
13-24ml/min; study B) there was a slower mean decline in 
GFR (3,6 ml/min/year). MDRD study revealed a longer 
time to renal failure in patients with a GFR less than 
25ml/min/l ,73m2, it is indicated to prescribe dietary protein 
intakes of 0,6g/kg/day (Table 1). 
Many of human controlled studies have not shown an un­
equivocal benefit by strong evidence, including the lack of 
randomization, the use of retrospective analysis, that criti­
cized the concentrations of serum creataine or creatinine 
clearance to assess the changes of decline of renal function. 
In the results of the intention-to-tread analysis did not prove 
a beneficial effect of the very-low-protein diet (0,28g pro­
tein/kg/day) compared to the low-protein diet (0,58 protein 
g/kg/day) in the progression of renal disease (no significant 
effect on the time to renal failure or death). Secondary anal­
yses of the MDRD study (2,3) revealed a longer time to re­
nal failure in group В in patients with lower total protein in­
take but did not use the keto-amino acid supplement with 
GFR less than 25ml/min. 
In cases of advanced GFR values less than 25ml/min a diet 
providing 0,60g proteiiVkg body weight/day may reduce 
the rate of loss of renal function or delay the early onset of 
the uremic syndrome of end-stage renal disease (ESRD). 
An adequate intake of calories must also be insured at rise 
of catabolizing body protein if the caloric intake is inade-
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Table I . Scheme for protein restriction in dependence on renal function 
Stage of CRF Daily permitted protein Restriction of Daily pemiitted Ну perl ipidemia diet + 
supply phosphate calcium supply statine 
Initial CRF 
(CrCI 50-70ml/min) ОД-1,2 g/kg bw/d <900 mg/d 500-1200 mg/d aimed LDL <I00 mg'dl 1 
Mild CRF 
(CrCI 25-50 ml/min) 
0,6-0,8 g/kg bw/d 700-900 mg/d 1000-1200 mg/d 
1 
total chol. < 160 mg'dl 
Advanced CRF Protein balanced diet <700 mg/d 1200-1500 mg/d 
(CrCI 5-25 ml/min) ; <0,6 g^g bw/d ca 45g Ca carbonate 1200-1800 mg/d total chol. <210 mg/dl 
Hemodialysis 
(CrCI <5 ml/min) 
1,2-1,4 g/kg bw/d 





quate on periodic assessment of dietary adequacy and com­
pliance (by measuring the 24h urinary excretion of urea). 
The meta-analysis of effect of dietary protein restriction on 
the progression of diabetic and non-diabetic renal diseases 
were considered also its importance in adequate correction 
of uremic syndrome and an absence of side effects in the 
long or short term of this nutritional regimen. Thus can vir­
tually arrest the downward course of CRF in predialytic pa­
tients for at least one year (9). 
The use of low-protein diets and lipid-lowering regimen for 
individual patients to a greater or lesser extent when some 
factors determine a Kt/v in dialysis patients result a lower 
than that prescribed. There is a direct relationship between 
food intake during hemodialysis and measurement of op­
tional value of standard kt/v (has to be 1,2 for non-diabetic 
patients and 1,4 for diabetics, and Urea Reduction Percent-
age/PRU) of 65-70% (NKF - DOQI Guideline limits) in 
the determination of dialysis adequacy. 
Adequate hemodialysis achieves a high survival rate, a low 
morbidity and a better standard of living, lntradialysis food 
intake influences the result of dialysis that the effective cir­
culating volume diseases. A week after, it to be calculate 
again in low-protein regimen of food intake (6). 
Dietary phosphorus restriction should begin when the glo­
merular filtration rate is a 60-70 ml/min and can be 
achieved by restricted dietary phosphorus intake. Phospho­
rus is contained in almost all foods and it is difficult to limit 
the intake of dietary phosphorus to less than 900-1 OOOmg 
per day. That 60-70% of consumed phosphate was ab­
sorbed from low-phosphate diet in inadequate dialysis, 
when safe phosphate-binding therapy. 
Involved mechanisms of renal tabular reabsorption of or­
ganic phosphate are under the control of dietary. Endocrine 
and metabolic factors, but not fully clarified in terms of ho­
meostasis and pathophysiology. Vitamin D therapy used to 
manage secondary hyperparathyroidism may increase in­
testinal absorption of both calcium and phosphate. Excess 
total body calcium may not be reflected in serum calcium 
levels for patients with renal failure and most patients are in 
positive calcium balance. 
The excessive calcium intake that oral or i.v. calcitriol can 
be used safely only when calcium and phosphorus balances 
are controlled. Approximately 50% prevalence of 
hyperphosphatemia (>l,6mmol/L) and cutoff point for 
"poor control" was defined >2,1 mmol/L which was pres­
ent in 39% of dialysis population. Elevated Са x P product 
was associated with a higher risk of mortality statistically 
significant above 5,8 mmoP/LA Poor phosphorus control 
significantly increased the risk for cardiovascular death (7). 
Some authors recommended target levels of less than 
1,8mmol/L for phosphorus and less than 4.4mmol7L2 for 
Ca x P product in permanent nutritional status. Controlling 
the Ca x P product through dietary phosphorus restriction 
and phosphorus-binding agents is the most common means 
of preventing metastatic calcifications into tissues. 
The dietary therapy in CRF patients is usually recom­
mended on a conventional low-protein (0,6g/kg b. w. per 
day) diet. 
A very important step in the clinical management in the 
predialytic stage of chronic uremic patients with (creatinine 
clearance less than 25ml/min/l ,73m2 serum creatinine level 
below 350mmol/L) has been the assessment of nutritional 
status a very-low-protein diet (0,3g/kg b. w. per day) sup­
plemented with essential amino acids and keto acids as a 
factor correlating with a progression of CRF. Nowadays 
there are numerous studies about the effect of using mix­
tures of essential amino acids (Propac, Promod, Magnacal). 
Progressive protein-energy malnutrition is a heavy compli­
cation in patients on periodical hemodialysis treatment in 
30% of them and in all with marked anaemia. On periodical 
hemodialysis treatment oral intake of nutritional supple­
ments shows the possibility to treat protein-energy malnu­
trition. The protein intake to be increased to the preferential 
norm of 1,2-1,4g/kg b. w. /day by Nutridial (Nutrim Co), a 
Bulgarian nutritional supplement with protein concentra­
tion of 62%. This is significantly cheaper compared to same 
treatment with other foreign analogue (9). 
Keto acid supplementation (ketoanalogue given in the form 
of Ketosteril®, Fresenius, Germany, or Clintec®, France) 
slows progression of renal failure more than amino acids 
with a diet containing 0,3g per kg ideal weight of protein 
and 7-9mg per kg ideal weight of phosphorus Also added 
with vitamins, calcium carbonate, or lOg per day of essen­
tial amino acids. There has been no change in blood pres­
sure, phosphaturia and proteinuria, but the nutrition has 
been maintained. Keto acid supplemented regimen halted 
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the progression of moderately-severe C R F for at least an 
year (herein after serum creatinine levels at changeover of 
6,6-7,4mg/dl)(10). 
low Na r of 20-40mmol/day diet may reduce salt reten­
tion mainly in nephrotic syndrome) and the danger of di­
uretic therapy. In patients with heavy nephritic syndrome 
(proteinuria >5g/day), hypoproteinuria until the serum al­
bumin below 30g/l, with azothemia (>150mmol/L 
creatinine) and an increase at over 1,5 times in total choles-
~rol with increased production of very low density lipopro­
tein ( V L D L ) and low density lipoprotein ( L D L ) In diabetic 
patients combined pancreatic and kidney transplantation 
before heavy accelerated macro- and microvasculopathic 
complications and before muscle wasting precludes reha­
bilitation affords to retain functional status, thereby avoid­
ing a risk of posttransplantation mortality. 
In protein-energy malnutrition of patients on hemodialysis 
there was no correlation between decreased TNF-a, 
transferrin or albumin levels and reduced anthropometric 
parameters in the high prevalence of malnutrition in CRF 
children, which becomes more pronounced when treatment 
by hemodialysis is initiated (1). 
For haemodalysis patients with diabetic nephropathy the 
diet does appear to affect the response to epoietin. Differ­
ences in mean survival time were significant between those 
with cardiovascular disease and without cardiovascular dis­
ease (5). Treatment of renal anaemia with epoetin reduces 
oxidative stress as the concomitant administration of vita­
min С and vitamin Е (15mg/kg/daily) may improve this 
therapeutic effect (10). 
The low-protein diet decreases the risk of highly prevalent 
comorbid risk factors through progressive CRF that plague 
the long-duration restricting life quality optimal food in­
take, especially in atherosclerotic heart disease and 
cerebrovascular catastrophes that induce a high rate of 
withdrawal from food (as a form of suicide). Compliance 
with prescribed amino acids and keto analogues was as­
sessed by questioning the patients by a physician and dieti-
ian. 
The number of patients with ESRD has increased over the 
past 10 years and continues to grow at a rate of 7-9% per 
year in the United States and with prevalence rate of a 400 
persons per million in Europe that the financial cost of car­
ing for them is enormous, particularly in face of economic 
health state aided resources. Therefore, the development of 
dietary therapy at predialytic stage to prevent, or at least to 
slow into years the progression of CRF, greatly contisuted 
to the development a new medical strategy: challenge to 
nephrologists and hopes for patients with CRF. 
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